Article Information
History
- June 12, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Dongeon Kim1,2,#,
- Wen Tian1,2,#,
- Timothy Ting-Hsuan Wu2,3,
- Menglan Xiang1,2,
- Ryan Vinh1,2,
- Jason Chang1,2,
- Shenbiao Gu1,2,
- Seunghee Lee1,2,
- Yu Zhu1,2,
- Torrey Guan1,2,
- Emilie Claire Schneider1,2,
- Evan Bao1,2,
- J. Brandon Dixon4,
- Peter Kao2,
- Junliang Pan1,2,
- Stanley G. Rockson2,
- Xinguo Jiang1,2,* and
- Mark Robert Nicolls1,2,*
- 1VA Palo Alto Health Care System, Palo Alto, California, USA
- 2Stanford University School of Medicine, Stanford, California, USA
- 3Department of Biochemistry, Stanford Bio-X, Stanford, California, USA
- 4Georgia Institute of Technology, Atlanta, Georgia, USA
- ↵*To whom correspondence may be addressed. E-mail: mnicolls{at}stanford.edu; xinguoj{at}stanford.edu
↵# These authors contributed equally to this work
Posted June 12, 2023.
Abnormal lymphatic S1P signaling aggravates lymphatic dysfunction and tissue inflammation
